CC Earnings Prediction
The chart below shows how CC performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CC sees a +0.21% change in stock price 10 days leading up to the earnings, and a -4.69% change 10 days following the report. On the earnings day itself, the stock moves by +1.80%. This data can give you a slight idea of what to expect for the next quarter's release.
CC Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
1.39B
2.42%
-7.13%
Gross Margin
19.73%
7.40%
3.19%
Operating Margin
5.74%
8100.00%
-29.91%
Net Margin
-0.57%
-70.16%
-68.33%
EPS
-0.05
-70.59%
-72.22%
No Data Available
CC Earnings Analysis
Chemours Co Corporation (CC.N) Earnings Conference Call
Positive
Earnings Beat Expectations: Chemours Company beat earnings expectations with reported EPS of $0.11, exceeding the expected $0.10.
Quarterly Sales Record: The TSS business achieved a quarterly sales record, driven by a 23% year-over-year growth in Opteon Refrigerants, supported by regulatory transitions in the US and EU.
Cost Savings Achievement: The TT Transformation Plan yielded approximately $140 million in annual savings, exceeding the initial target of $125 million, contributing to a net increase in adjusted EBITDA margins.
Internal Control Remediation: The company fully remediated four material weaknesses in internal control, marking a significant milestone in their operational integrity.
Leadership Team Enhancement: The appointment of Damian Gumpel as President of Chemours’ TT Business and Diane Picho as Chief Enterprise Enablement Officer strengthens the leadership team and supports strategic execution.
Cost Savings Initiative: Chemours is on track to deliver $250 million in run rate cost savings by the end of 2025, with half of this target expected from the TT Transformation Plan.
Teflon PFA Production Growth: The high purity Teflon PFA resin production line for semiconductor customers is ramping up successfully, indicating growth potential in this market.
Opteon Refrigerants Growth Outlook: The company anticipates continued double-digit growth in Opteon Refrigerants throughout 2025, driven by regulatory demand and market transitions.
Projected EBITDA Improvement: Chemours expects improved overall results for 2025 compared to 2024, with a projected adjusted EBITDA range of $825 million to $975 million, depending on macroeconomic conditions.
Negative
Q4 Sales Decline: Consolidated net sales for Q4 2024 were approximately $1.4 billion, down 1% compared to the prior year quarter, driven by a 3% decline in pricing.
Net Sales Decline: Consolidated net sales for the full year 2024 were approximately $5.8 billion, down 5% compared to the prior year, primarily due to a 4% pricing decrease.
Adjusted EBITDA Decline: Adjusted EBITDA for the full year decreased to $786 million from $1 billion in the prior year, primarily driven by pricing decreases across all businesses and higher costs in TSS and corporate expenses.
Net Loss Comparison: Chemours reported a net loss of $8 million for Q4 2024, compared to a net loss of $18 million in the prior year, indicating ongoing financial challenges despite a slight improvement.
Net Income Decline: Consolidated adjusted net income for Q4 2024 was $16 million, down from $46 million in the prior year quarter, largely due to favorable tax impacts in the previous year.
APM Segment Sales Decline: APM segment sales were softer than anticipated due to weaker conditions in economically sensitive end markets and lower demand for Nafion membranes, negatively impacting performance solutions.
Increased Corporate Expenses: Corporate expenses increased by $20 million in Q4 2024 compared to the prior year, driven by changes in reserves related to legacy asbestos matters.
Cash Flow Decline: The company experienced a significant decline in cash provided by operating activities, down to $138 million from $482 million in the same quarter last year, reflecting operational challenges.
Cash Flow Challenges: For the full year, Chemours had outflows of operating cash of $633 million compared to inflows of $556 million in the prior year, indicating cash flow issues.
APM Segment EBITDA Decline: The APM segment reported a 41% decrease in adjusted EBITDA for the full year, primarily due to pricing decreases and lower sales volumes.
CC FAQs
How does CC typically perform around its earnings report dates?
Is Chemours Co (CC) Q4 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
CC Earning Call Sentiment
The Chemours Company (NYSE:CC) Q4 2024 Earnings Call Transcript
CC.N
5.11%Positive
The earnings call summary and Q&A reveal mixed signals. While there are positives like improved net income, strong TT EBITDA growth, and promising Opteon growth, there are concerns about operational headwinds, increased corporate expenses, and vague management responses on key issues. The market cap suggests a moderate reaction, and the overall sentiment is balanced by optimistic guidance and cost savings, offset by weak Q4 sales guidance and unclear future regulatory impacts. Thus, a neutral stock price movement is expected over the next two weeks.
